A floating 3D printed polypill formulation for the coadministration and sustained release of antihypertensive drugs
A floating 3D printed polypill formulation for the coadministration and sustained release of antihypertensive drugs
Polypharmacy is a common issue, especially among elderly patients resulting in administration errors and patient inconvenience. Hypertension is a prevalent health condition that frequently leads to polypharmacy, as its treatment typically requires the co-administration of more than one different Active Pharmaceutical Ingredients (API's). To address these issues, floating hollow torus-shaped dosage forms were developed, aiming at providing prolonged gastric retention and sustained drug release. The dosage forms (polypills) containing three anti-hypertensive API's (diltiazem (DIL), propranolol (PRP) and hydrochlorothiazide (HCTZ)) were created via Fused Deposition Modelling 3D printing. A multitude of the dosage forms were loaded into a capsule and the resulting formulation achieved prolonged retention times over a 12-hour period in vitro, by leveraging both the buoyancy of the dosage forms, and the "cheerios effect" that facilitates the aggregation and retention of the dosage forms via a combination of surface tension and shape of the objects. Physicochemical characterization methods and imaging techniques were employed to investigate the properties and the internal and external structure of the dosage forms. Furthermore, an ex vivo porcine stomach model revealed substantial aggregation, adhesion and retention of the 3D printed dosage forms in porcine stomach. In vitro dissolution testing demonstrated almost complete first-order release of PRP and DIL (93.52 % and 99.9 %, respectively) and partial release of HCTZ (65.22 %) in the 12 h timeframe. Finally, a convolution-based single-stage approach was employed in order to predict the pharmacokinetic (PK) parameters of the API's of the formulation and the resemblance of their PK behavior with previously reported data.
3D printing, Antihypertensive, Cheerios effect, Floating, Polypills, Sustained release
Zgouro, Paola
7473a8b4-cd8a-469e-bab6-7a33882e019c
Katsamenis, Orestis L.
8553e7c3-d860-4b7a-a883-abf6c0c4b438
Moschakis, Thomas
8dd90cda-c545-4947-8e10-2359e7a84095
Eleftheriadis, Georgios K.
dc117757-1fb2-4a25-aebe-be56bdf9da18
Kyriakidis, Athanasios S.
3e67dd93-faa2-4664-85a0-2b8bfe4d6b37
Chachlioutaki, Konstantina
aa15e449-9ebc-4a23-a5a3-4a0a1327fc8e
Kyriaki Monou, Paraskevi
e87c8c47-8cf9-401d-afe3-fe04f08866f1
Ntorkou, Marianna
21903d19-4049-430f-b0e7-e9e789d2f0bc
Zacharis, Constantinos K.
0f09a9fe-0bea-4ac2-a93a-51fc3d6bb1a5
Bouropoulos, Nikolaos
fadadea1-2aa2-4cd9-a7e5-33ba790cd45f
Fatouros, Dimitrios G.
4a716c96-a8ba-4fbf-b3db-3b2a3a2794c4
Karavasili, Christina
f174d197-8ba7-4765-adc8-99fa2f1c86fa
Gioumouxouzis, Christos I.
6bbfb151-763a-48dc-8d1f-9cabd27c8d11
25 April 2024
Zgouro, Paola
7473a8b4-cd8a-469e-bab6-7a33882e019c
Katsamenis, Orestis L.
8553e7c3-d860-4b7a-a883-abf6c0c4b438
Moschakis, Thomas
8dd90cda-c545-4947-8e10-2359e7a84095
Eleftheriadis, Georgios K.
dc117757-1fb2-4a25-aebe-be56bdf9da18
Kyriakidis, Athanasios S.
3e67dd93-faa2-4664-85a0-2b8bfe4d6b37
Chachlioutaki, Konstantina
aa15e449-9ebc-4a23-a5a3-4a0a1327fc8e
Kyriaki Monou, Paraskevi
e87c8c47-8cf9-401d-afe3-fe04f08866f1
Ntorkou, Marianna
21903d19-4049-430f-b0e7-e9e789d2f0bc
Zacharis, Constantinos K.
0f09a9fe-0bea-4ac2-a93a-51fc3d6bb1a5
Bouropoulos, Nikolaos
fadadea1-2aa2-4cd9-a7e5-33ba790cd45f
Fatouros, Dimitrios G.
4a716c96-a8ba-4fbf-b3db-3b2a3a2794c4
Karavasili, Christina
f174d197-8ba7-4765-adc8-99fa2f1c86fa
Gioumouxouzis, Christos I.
6bbfb151-763a-48dc-8d1f-9cabd27c8d11
Zgouro, Paola, Katsamenis, Orestis L., Moschakis, Thomas, Eleftheriadis, Georgios K., Kyriakidis, Athanasios S., Chachlioutaki, Konstantina, Kyriaki Monou, Paraskevi, Ntorkou, Marianna, Zacharis, Constantinos K., Bouropoulos, Nikolaos, Fatouros, Dimitrios G., Karavasili, Christina and Gioumouxouzis, Christos I.
(2024)
A floating 3D printed polypill formulation for the coadministration and sustained release of antihypertensive drugs.
International Journal of Pharmaceutics, 655, [124058].
(doi:10.1016/j.ijpharm.2024.124058).
Abstract
Polypharmacy is a common issue, especially among elderly patients resulting in administration errors and patient inconvenience. Hypertension is a prevalent health condition that frequently leads to polypharmacy, as its treatment typically requires the co-administration of more than one different Active Pharmaceutical Ingredients (API's). To address these issues, floating hollow torus-shaped dosage forms were developed, aiming at providing prolonged gastric retention and sustained drug release. The dosage forms (polypills) containing three anti-hypertensive API's (diltiazem (DIL), propranolol (PRP) and hydrochlorothiazide (HCTZ)) were created via Fused Deposition Modelling 3D printing. A multitude of the dosage forms were loaded into a capsule and the resulting formulation achieved prolonged retention times over a 12-hour period in vitro, by leveraging both the buoyancy of the dosage forms, and the "cheerios effect" that facilitates the aggregation and retention of the dosage forms via a combination of surface tension and shape of the objects. Physicochemical characterization methods and imaging techniques were employed to investigate the properties and the internal and external structure of the dosage forms. Furthermore, an ex vivo porcine stomach model revealed substantial aggregation, adhesion and retention of the 3D printed dosage forms in porcine stomach. In vitro dissolution testing demonstrated almost complete first-order release of PRP and DIL (93.52 % and 99.9 %, respectively) and partial release of HCTZ (65.22 %) in the 12 h timeframe. Finally, a convolution-based single-stage approach was employed in order to predict the pharmacokinetic (PK) parameters of the API's of the formulation and the resemblance of their PK behavior with previously reported data.
Text
R1-manuscript-Accepted-preProofs
- Accepted Manuscript
Restricted to Repository staff only until 3 April 2025.
Request a copy
Text
preProofs_1-s2.0-S0378517324002928-main
- Proof
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 26 March 2024
e-pub ahead of print date: 28 March 2024
Published date: 25 April 2024
Additional Information:
Copyright © 2024 Elsevier B.V. All rights reserved.
Keywords:
3D printing, Antihypertensive, Cheerios effect, Floating, Polypills, Sustained release
Identifiers
Local EPrints ID: 489543
URI: http://eprints.soton.ac.uk/id/eprint/489543
ISSN: 0378-5173
PURE UUID: 19adf0c6-f78c-4199-9a58-986cbf1c3a78
Catalogue record
Date deposited: 26 Apr 2024 16:55
Last modified: 24 May 2024 01:43
Export record
Altmetrics
Contributors
Author:
Paola Zgouro
Author:
Thomas Moschakis
Author:
Georgios K. Eleftheriadis
Author:
Athanasios S. Kyriakidis
Author:
Konstantina Chachlioutaki
Author:
Paraskevi Kyriaki Monou
Author:
Marianna Ntorkou
Author:
Constantinos K. Zacharis
Author:
Nikolaos Bouropoulos
Author:
Dimitrios G. Fatouros
Author:
Christina Karavasili
Author:
Christos I. Gioumouxouzis
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics